1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsObservational Studies in Individuals Living with Autism Spectrum Disorders (ASD) Along the Lifespan (U01) is sponsored by National Institute on Aging (NIA). This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - Biomarkers of Cognitive Decline and Dementias of Aging in Individuals within the Autism Spectrum Biomarkers of Cognitive Decline and Dementias of Aging in Individuals within the Autism Spectrum Agency: National Institutes of Health Assistance Listings: 93. 866 -- Aging Research Last Updated: May 13, 2026 View version history on Grants.
gov The National Institute on Aging (NIA) intends to publish a Notice of Funding Opportunity (NOFO) to invite applications to conduct observational studies in individuals living with Autism Spectrum Disorders (ASD) along the lifespan.
The overarching goal is to determine the occurrence of age-related neurodegeneration across the heterogeneities of the ASD spectrum, characterize the physiopathology and manifestation of Alzheimer's disease (AD) and AD-related dementias (ADRD) in ASD, and, ultimately, develop precision-medicine strategies tailored to this understudied population.
It is expected that proposed studies pursue deep phenotyping of aging individuals across the ASD spectrum, along with the characterization/validation of existing biomarkers of age-related cognitive decline and/or dementia in this population, and/or the discovery of novel ones. Applications are not being solicited at this time.
Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO intends to utilize the U01 activity code.
This NOFO encourages collaborations between investigators with expertise in autism and those with expertise in aging and dementia, fostering interactions between established centers for neurodevelopmental research and centers studying age-related cognitive decline.
Private institutions of higher education Independent school districts Public and state institutions of higher education For-profit organizations other than small businesses Other Native American tribal organizations Nonprofits non-higher education with 501(c)(3) Federally recognized Native American tribal governments Public and Indian housing authorities Grantor contact information Alessandra Rovescalli, Ph. D.
National Institute on Aging (NIA) No documents are currently available. Link to additional information Estimated Application Due Date : Estimated Due Date Description : Estimated Project Start Date : Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Your account requires additional identity verification.
According to the current listing, eligibility includes: This NOFO encourages collaborations between investigators with expertise in autism and those with expertise in aging and dementia. Confirm the full requirements in the official notice before applying.
Observational Studies in Individuals Living with Autism Spectrum Disorders (ASD) Along the Lifespan (U01) is funded by National Institute on Aging (NIA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The National Institute on Aging's FY 2026 AD/ADRD portfolio consolidates the dementia research infrastructure layer — NCRAD, NACC, the new AI and Technology Collaboratory Coordinating Center — into a small number of large, often single-source cooperative agreements. The $113M new-research increment goes elsewhere. For investigators submitting in FY 2026, the structural change matters more than the headline dollar number.
Read articleSeven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read article